|
HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
|
journal
|
April 1990 |
|
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
|
journal
|
October 2014 |
|
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
|
journal
|
October 2013 |
|
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4 + T Cells from Effectively Treated Participants
|
journal
|
October 2017 |
|
Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity
|
journal
|
August 2021 |
|
Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape
|
journal
|
April 2017 |
|
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
|
journal
|
July 2019 |
|
Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model
|
journal
|
December 2006 |
|
Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy
|
journal
|
September 2007 |
|
HIV replication and latency in monocytes and macrophages
|
journal
|
January 2021 |
|
HIV-specific cytotoxic T lymphocytes in seropositive individuals
|
journal
|
July 1987 |
|
Viral dynamics in human immunodeficiency virus type 1 infection
|
journal
|
January 1995 |
|
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
|
journal
|
January 1995 |
|
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
|
journal
|
May 1997 |
|
Decay characteristics of HIV-1-infected compartments during combination therapy
|
journal
|
May 1997 |
|
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
|
journal
|
January 2000 |
|
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
|
journal
|
May 1999 |
|
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|
journal
|
July 2012 |
|
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
|
journal
|
December 2013 |
|
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
|
journal
|
January 2015 |
|
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
|
journal
|
March 2010 |
|
Defective proviruses rapidly accumulate during acute HIV-1 infection
|
journal
|
August 2016 |
|
Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
|
journal
|
February 1997 |
|
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
|
journal
|
December 1995 |
|
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
|
journal
|
May 2003 |
|
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
|
journal
|
January 2021 |
|
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses
|
journal
|
January 2019 |
|
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
|
journal
|
January 2020 |
|
Distinct viral reservoirs in individuals with spontaneous control of HIV-1
|
journal
|
August 2020 |
|
Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models
|
journal
|
December 2016 |
|
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
|
journal
|
September 1997 |
|
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|
journal
|
September 1997 |
|
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
|
journal
|
March 2008 |
|
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
|
journal
|
March 2008 |
|
Clonally expanded CD4 + T cells can produce infectious HIV-1 in vivo
|
journal
|
February 2016 |
|
Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy
|
journal
|
July 2016 |
|
Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART
|
journal
|
April 2017 |
|
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane
|
journal
|
February 2018 |
|
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption
|
journal
|
April 2020 |
|
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA
|
journal
|
July 2020 |
|
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
|
journal
|
November 1997 |
|
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response
|
journal
|
November 2004 |
|
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
|
journal
|
September 2004 |
|
Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract
|
journal
|
September 2004 |
|
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
|
journal
|
June 2009 |
|
Proliferation of latently infected CD4 + T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
|
journal
|
March 2017 |
|
Biphasic Decay of Latently Infected CD4 + T Cells in Acute Human Immunodeficiency Virus Type 1 Infection
|
journal
|
December 2000 |
|
HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy
|
journal
|
July 2014 |
|
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
|
journal
|
August 2020 |
|
Similar Frequency and Inducibility of Intact Human Immunodeficiency Virus-1 Proviruses in Blood and Lymph Nodes
|
journal
|
December 2020 |
|
Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248
|
journal
|
June 2013 |
|
Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
|
journal
|
August 2013 |
|
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
|
journal
|
April 2015 |
|
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b)
|
journal
|
January 2015 |
|
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
|
journal
|
June 2014 |
|
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
|
journal
|
July 2014 |
|
Quiescent T Lymphocytes as an Inducible Virus Reservoir in HIV-1 Infection
|
journal
|
October 1991 |
|
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
|
journal
|
March 1996 |
|
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
|
journal
|
November 1997 |
|
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|
journal
|
November 1997 |
|
Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection
|
journal
|
April 1998 |
|
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes
|
journal
|
February 1999 |
|
Different human resting memory CD4 + T cell subsets show similar low inducibility of latent HIV-1 proviruses
|
journal
|
January 2020 |
|
Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells
|
journal
|
June 2006 |
|
Dynamics of Simian Immunodeficiency Virus Two-Long-Terminal-Repeat Circles in the Presence and Absence of CD8 + Cells
|
journal
|
April 2018 |
|
Gastrointestinal T Lymphocytes Retain High Potential for Cytokine Responses but Have Severe CD4 + T-Cell Depletion at All Stages of Simian Immunodeficiency Virus Infection Compared to Peripheral Lymphocytes
|
journal
|
August 1998 |
|
Molecular Characterization of Preintegration Latency in Human Immunodeficiency Virus Type 1 Infection
|
journal
|
September 2002 |
|
Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles
|
journal
|
April 2002 |
|
Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication
|
journal
|
April 2002 |
|
Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus
|
journal
|
July 2005 |
|
Kinetics of Human Immunodeficiency Virus Type 1 Decay following Entry into Resting CD4+ T Cells
|
journal
|
January 2005 |
|
In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA
|
journal
|
April 2005 |
|
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
|
journal
|
January 1994 |
|
HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy
|
journal
|
September 2019 |
|
BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo
|
journal
|
March 2020 |
|
Macrophages sustain HIV replication in vivo independently of T cells
|
journal
|
March 2016 |
|
Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells
|
journal
|
June 2017 |
|
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
|
journal
|
January 2018 |
|
Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy
|
journal
|
February 2020 |
|
Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy
|
journal
|
November 2015 |
|
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
|
journal
|
January 2018 |
|
CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells
|
journal
|
January 2010 |
|
In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells
|
journal
|
January 2010 |
|
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
|
journal
|
February 2013 |
|
Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir
|
journal
|
March 2017 |
|
Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration
|
journal
|
July 2017 |
|
Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs
|
journal
|
January 2015 |
|
Life and Death of Activated T Cells: How Are They Different from Naïve T Cells?
|
journal
|
December 2017 |
|
Different Dynamics of CD4 + and CD8 + T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection
|
journal
|
October 2003 |
|
The HIV-1 latent reservoir is largely sensitive to circulating T cells
|
journal
|
October 2020 |